Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02GFK
|
||||
| Former ID |
DNC008620
|
||||
| Drug Name |
3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529624] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H14N2O
|
||||
| Canonical SMILES |
COC1=CC2=C(C=C1)C=C(C=C2)C3=C(C=CN=C3)N
|
||||
| InChI |
1S/C16H14N2O/c1-19-14-5-4-11-8-13(3-2-12(11)9-14)15-10-18-7-6-16(15)17/h2-10H,1H3,(H2,17,18)
|
||||
| InChIKey |
WAIWXNYKRBBVSH-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 2D6 | Target Info | Inhibitor | [529624] | |
| Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [529624] | ||
| PathWhiz Pathway | Steroidogenesis | ||||
| WikiPathways | Metapathway biotransformation | ||||
| Tamoxifen metabolism | |||||
| Oxidation by Cytochrome P450 | |||||
| Vitamin D Receptor Pathway | |||||
| Aripiprazole Metabolic Pathway | |||||
| Fatty Acid Omega Oxidation | |||||
| Codeine and Morphine MetabolismWP702:Metapathway biotransformation | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| Corticotropin-releasing hormone | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.